s6y
Company name or ticker
Search
BridgeBio Oncology Therapeutics, Inc.
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Filed
Monday, July 21, 2025
Accession number
0001213900-25-065883
Documents
FORM 425
425
On sec.gov
Filing index
All files
Complete submission text
SGML header